home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Cut Off the Food to Spite the Tumour

  June, 26 2008 8:46
your information resource in human molecular genetics

Researchers have uncovered the important role of a molecule in directing the formation of blood supply to tumours. The protein receptor VEGFR-3 could represent a new drug target for cancer therapy.

Angiogenesis - the process of growing new blood vessels - involves a complex network of signalling molecules known as growth factors and their receptors. Cancer cells manipulate this process by inappropriately sending out growth factors to generate their own blood vessel network providing nutrients for growth.

The receptor VEGFR-2 is already known to be important for angiogenesis and is a major target for drug development. In Nature, Kari Alitalo and colleagues establish that the related protein VEGFR-3 has a previously unknown role in signalling blood vessel 'sprouting'. Using antibodies to block both receptors, the team found an additive effect in inhibition of tumour growth by effectively starving the cancer cells.

The findings could help to improve the efficacy of existing anti-angiogenic therapies and may prove useful in the combat against drug resistance, say the authors.


Kari Alitalo (University of Helsinki, Finland)
E-mail: kari.alitalo@helsinki.fi

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.